Rank #1112CRSP

CRISPR Therapeutics AG

$54.64

2.09% (Daily)

Market Cap

$5.24B

Revenue

$3.51M

Rank by MCap

#1112

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Samarth Kulkarni Ph.D.

Headquarters

Zug

About CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell the...